TAFERO-EM Tablet is a prescription medication used for the treatment and prevention of HIV-1 infection in adults and adolescents. It is commonly used as part of a combination antiretroviral therapy (ART) regimen for managing HIV or as a pre-exposure prophylaxis (PrEP) to reduce the risk of acquiring HIV in individuals at high risk.

Active Ingredients:

TAFERO-EM Tablet contains two active ingredients:

1. Tenofovir alafenamide (TAF) – 25 mg

• A nucleoside reverse transcriptase inhibitor (NRTI) that disrupts HIV replication.

1. Emtricitabine (FTC) – 200 mg

• Another NRTI that inhibits the reverse transcriptase enzyme, essential for HIV replication.

How Does TAFERO-EM Tablet Work?

The combination of TAF and FTC in TAFERO-EM Tablet blocks the action of the reverse transcriptase enzyme, an essential enzyme used by HIV to replicate its genetic material. This action helps.

• Prevent the virus from multiplying and spreading.
• Maintain or improve immune function.

When used as PrEP, TAFERO-EM creates a protective barrier in the body, reducing the likelihood of HIV infection after potential exposure.

Key Benefits:

• Helps suppress the HIV virus to undetectable levels when taken as prescribed.
• Reduces the risk of HIV transmission when viral load is controlled.
• Provides a reliable option for PrEP in individuals at risk of HIV exposure.
• A convenient once-daily dosing regimen.

Dosage and Administration:

• For HIV-1 treatment: Take 1 tablet once daily as part of a combination ART regimen, as prescribed by your healthcare provider.
• For PrEP: Take 1 tablet once daily, consistently, as directed by your doctor.
• TAFERO-EM can be taken with or without food.

For optimal effectiveness, it is important to adhere strictly to the prescribed regimen.

FAQs:

1. What is TAFERO-EM Tablet used for?

TAFERO-EM Tablet is used for:

• Treatment of HIV-1 infection in adults and adolescents as part of a combination antiretroviral therapy (ART).
• Pre-exposure prophylaxis (PrEP) to reduce the risk of acquiring HIV in individuals at high risk of exposure.

2. What are the active ingredients in TAFERO-EM Tablet?

TAFERO-EM Tablet contains:

• Tenofovir alafenamide (TAF) – 25 mg
• Emtricitabine (FTC) – 200 mg
• These are nucleoside reverse transcriptase inhibitors (NRTIs) that help prevent HIV from replicating in the body.

3. How does TAFERO-EM Tablet work?

TAFERO-EM works by blocking the action of the reverse transcriptase enzyme, which HIV uses to replicate its genetic material. This reduces the amount of HIV in the body, supports immune function, and prevents the virus from spreading further. When used as PrEP, it creates a barrier against HIV infection.

4. How should I take TAFERO-EM Tablet?

• Take 1 tablet once daily with or without food, as prescribed by your healthcare provider.
• For PrEP, ensure daily adherence to maintain effective protection against HIV.

5. What are the common side effects of TAFERO-EM Tablet?

Common side effects may include:

• Nausea
• Headache
• Fatigue
• Diarrhea
• Dizziness

6. Is regular monitoring required while taking TAFERO-EM Tablet?

Yes, regular monitoring is essential, including:

• Kidney function tests to ensure proper kidney health.
• Bone health assessments, especially for individuals at risk of osteoporosis.
• HIV testing (if using for PrEP) to confirm HIV-negative status before and during use.

7. Can TAFERO-EM Tablet interact with other medications?

Yes, TAFERO-EM may interact with other drugs. Inform your healthcare provider about all medications, supplements, and over-the-counter products you are taking to avoid potential interactions.

8. Is TAFERO-EM safe to use during pregnancy?

If you are pregnant, planning to become pregnant, or breastfeeding, consult your doctor before using TAFERO-EM. Your doctor will assess the risks and benefits to determine the best course of treatment.

9. Can I drink alcohol while taking TAFERO-EM Tablet?

It is generally advisable to limit alcohol consumption, as excessive alcohol can increase the risk of liver-related side effects. Consult your doctor for specific guidance.